These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6321736)

  • 1. Structure-activity relationships among DNA gyrase inhibitors. Synthesis and biological evaluation of 1,2-dihydro-4, 4-dimethyl-1-oxo-2-naphthalenecarboxylic acids as 1-carba bioisosteres of oxolinic acid.
    Högberg T; Khanna I; Drake SD; Mitscher LA; Shen LL
    J Med Chem; 1984 Mar; 27(3):306-10. PubMed ID: 6321736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships among DNA-gyrase inhibitors. Synthesis and antimicrobial evaluation of chromones and coumarins related to oxolinic acid.
    Högberg T; Vora M; Drake SD; Mitscher LA; Chu DT
    Acta Chem Scand B; 1984; 38(5):359-66. PubMed ID: 6091380
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinolone antimicrobial agents. 2. Methylenedioxy positional isomers of oxolinic acid.
    Mitscher LA; Flynn DL; Gracey HE; Drake SD
    J Med Chem; 1979 Nov; 22(11):1354-7. PubMed ID: 533883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid.
    Psomas G; Tarushi A; Efthimiadou EK; Sanakis Y; Raptopoulou CP; Katsaros N
    J Inorg Biochem; 2006 Nov; 100(11):1764-73. PubMed ID: 16904184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA gyrase on the bacterial chromosome: possibility of two levels of action.
    Drlica K; Engle EC; Manes SH
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6879-83. PubMed ID: 6256766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
    J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimicrobial activity of DNA-gyrase inhibiting derivatives of 4-oxo-1,4-dihydro-3-pyridinecarboxylic acid.
    Bassini C; Bismara C; Carlesso R; Feriani A; Gaviraghi G; Marchioro C; Perboni A; Shaw RE; Tamburini B; Tarzia G
    Farmaco; 1993 Feb; 48(2):159-89. PubMed ID: 8388214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Gellert M; Mizuuchi K; O'Dea MH; Itoh T; Tomizawa JI
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4772-6. PubMed ID: 337300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxolinic acid-resistant mutants of Bacillus subtilis.
    Vazquez-Ramos JM; Mandelstam J
    J Gen Microbiol; 1981 Nov; 127(1):1-9. PubMed ID: 6279763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
    Sugino A; Peebles CL; Kreuzer KN; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4767-71. PubMed ID: 200930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
    J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sporulation by DNA gyrase inhibitors.
    Vazquez-Ramos JM; Mandelstam J
    J Gen Microbiol; 1981 Nov; 127(1):11-7. PubMed ID: 6279764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.
    Castora FJ; Vissering FF; Simpson MV
    Biochim Biophys Acta; 1983 Sep; 740(4):417-27. PubMed ID: 6309236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and appetite suppressant activity of 1-aryloxy-2-substituted aminomethyltetrahydronaphthalenes as conformationally rigid analogues of fluoxetine.
    Bhandari K; Srivastava S; Shankar G; Nath C
    Bioorg Med Chem; 2006 Apr; 14(8):2535-44. PubMed ID: 16337129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein.
    Gellert M; Fisher LM; O'Dea MH
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6289-93. PubMed ID: 230505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of gene expression in vitro to inhibitors of DNA gyrase.
    Yang HL; Heller K; Gellert M; Zubay G
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3304-8. PubMed ID: 226966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gyrase inhibitors increase the content of knotted DNA species of plasmid pBR322 in Escherichia coli.
    Ishii S; Murakami T; Shishido K
    J Bacteriol; 1991 Sep; 173(17):5551-3. PubMed ID: 1653211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.